Home / Pharmaceutical / Global Irritable Bowel Syndrome with Constipation drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Global Irritable Bowel Syndrome with Constipation drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Published: Oct 2017 | Published By: Acute Market Research

Irritable Bowel Syndrome with Constipation drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022, higher prevalence of IBS in developed world and prompt address to the need for advanced pharmaceutical measures will facilitate the dominance of Europe IBS-C drugs market on the global front.

IBS is prevalent in general population across the globe for a long period and has affected adversely in terms of medical costs and socioeconomic impact. Increased prevalence of lifestyle related diseases, growth in healthcare spending, augmented patient population suffering from gastrointestinal diseases and medical advancements are the prime contributors to the growth of IBS-C drugs market.

Europe is a combination of varied market trends mutually prevalent across the comprising countries, attributed by the cultural mix and healthcare infrastructures. The region has the largest share in the global IBS-C drugs market and was valued at USD 445.7 Mn in 2015. As IBS patient pool is the highest in the region, the demand for treatment options is also correspondingly high. The prevalence of IBS in European countries ranges from 5% to 25%.

IBS and CI are the two most common gastrointestinal disorders in North America. The conditions together affect more than 30 Million individuals as of 2014. North America also has the highest count of patients suffering from constipation. Evolved healthcare infrastructure, early bird commercialization of IBS-C drugs in the US, better reimbursement policies and higher awareness among both physicians and patient population are the major contributors to the dominance of North America in the global market.

In addition, Asia Pacific is expected to open further avenues for the international players in IBS-C market. APAC is emerging region with the huge scope for the pharmaceutical companies. Japan and China in particular are considered to be very promising countries for drugs market. As Asia is home to half of the world's population, and offers both a large relatively low-cost workforce in some countries and a potentially huge retail market, this region could be central to the future of the global economy.

APAC is the third largest market for the drugs of IBS are many big pharmaceutical companies are investing in for future growth. The number of patients suffering from irritable bowel syndrome accounts to almost 7% of the population. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants and largest number of patients after Japan.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approach Adopted
1.3.5 Key Points

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Lactic Acid Market

Chapter 3 Introduction
3.1 Introduction
3.2 Classification
3.3 Drivers
3.4 Restraints
3.5 Opportunities
3.6 Supply Chain
3.7 Porter’s five force analysis
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Degree of competition

Chapter 4 Global Lactic Acid Market, Application Analysis
4.1 Global Lactic Acid Market, by application type
4.3 Food & Beverages
4.3.1 Global demand of lactic acid from food & beverages applications, 2017 – 2025, USD Million), (Kilo Tons)
4.4 Pharmaceuticals
4.4.1 Global demand of lactic acid from pharmaceuticals applications, 2017 – 2025, (USD Million), (Kilo Tons)
4.5 Industrial applications
4.5.1 Global demand of lactic acid from industrial applications, 2017 – 2025, (USD Million), (Kilo Tons)
4.6 Personal Care Products
4.6.1 Global demand of lactic acid from personal care products applications, 2017 – 2025, (USD Million), (Kilo Tons)
4.2 Others
4.2.1 Global demand of lactic acid from others applications, 2017 – 2025, (USD Million), (Kilo Tons)

Chapter 5 Global Lactic Acid Market, Regional Analysis
5.1 Global Lactic Acid Market, regional analysis, (2017 – 2025)
5.2 North America
5.2.1 US Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.2.2 Canada Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.2.3Mexico Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3 Europe
5.3.1 Germany Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3.2 France Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3.3 UK Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3.4 Italy Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3.5 Russia Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.3.6 Rest of Europe Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.4 Asia Pacific
5.4.1 Japan Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.4.2 China Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.4.3 India Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.4.4 Australia Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.4.5 Rest of Asia Pacific Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.5 RoW
5.5.1 Brazil Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)
5.5.2 Rest of RoW Lactic Acid Market, 2017 – 2025, (USD Million), (Kilo Tons)

Chapter 6 Competitive Analysis
6.1 BASF
6.2 Jungbunzlauer
6.3 NatureWorks LLC
6.4 Archer Daniels Midland Company
6.5 Galactic S.A
6.6 Synbra Technology B.V.
6.7 The DOW Chemical Company
6.8 Corbion N.V.
6.9 Teijin Ltd
6.10 Plaxica

Chapter 7 Conclusion

TABLE 1 Global IBS-C drug market by geography 2017 - 2025 (USD Mn)
TABLE 2 Prominent IBS Treatment Drugs
TABLE 3 IBS Drugs List
TABLE 4 Global OIC drug market by drug type, 2017 - 2025 (USD Mn)
TABLE 5 Product Profile (Lubiprostone)
TABLE 6 Linaclotide market by region, 2017 - 2025 (USD Mn)
TABLE 7 Product Profile: Linaclotide
TABLE 8 Global Stimulant laxatives market by region, 2017 - 2025 (USD Mn)
TABLE 9 IBS Bisacodyl market by region, 2017 - 2025 (USD Mn)
TABLE 10 Product Profile: Bisacodyl
TABLE 11 IBS Senna market by region, 2017 - 2025 USD Mn)
TABLE 12 IBS Senna market by region, 2017 - 2025 USD Mn)
TABLE 13 Global Lactulose market by region, 2017 - 2025 (USD Mn)
TABLE 14 Product Profile: Lactulose
TABLE 15 Global Polyethylene Glycol market by region, 2017 - 2025 (USD Mn)
TABLE 16 Product Profile: Polyethylene Glycol
TABLE 17 IBS Professional Reference Statistics
TABLE 18 Product Profile: Plecanatide
TABLE 19 Global Prescribed IBS-C Drugs Market, by Prescription Type, 2017 - 2025 (USD Mn)
TABLE 20 Global Prescribed Branded IBS-C Drugs Market, by Geography, 2017 - 2025 (USD Mn)
TABLE 21 Global Prescribed Generic IBS-C Drugs Market, by Geography, 2017 - 2025 (USD Mn)
TABLE 22 Global Over the Counter IBS-C Drugs Market, by Geography, 2017 - 2025 (USD Mn)
TABLE 23 Global IBS-C Drugs Market, by Geography, 2017 - 2025 (USD Mn)
TABLE 24 Global IBS-C Drugs Market, by Geography, 2017 - 2025 (USD Mn)
TABLE 25 US IBS-C Drugs Market, by drug type, 2017 - 2025 (USD Mn)
TABLE 26 Europe IBS-C Drugs Market, by Country, 2017 - 2025 (USD Mn)

FIG. 1 Global IBS-C drugs market 2017 - 2025 (USD Mn)
FIG. 2 Global IBS-C Drugs Market, by Prescription Type, 2014 (%)
FIG. 3 IBS-C Prevalence Statistics, 2014 (%)
FIG. 4 Diets Responsible for IBS
FIG. 5 Percentage of Persons Aged 12 and Over with Depression by Age and Sex, US, 2009-2012
FIG. 6 Drugs For Irritable Bowel Syndrome Constipation
FIG. 7 Lifestyle and Home Remedies for IBS
FIG. 8 Drugs Pulled Off from The Market
FIG. 9 IBS Professional Reference Statistics
FIG. 10 Population of Asia by age group in various sub region, July 2013
FIG. 11 Global Lubiprostone Market, by Region, 2017 - 2025 (USD Mn)
FIG. 12 Pipeline Drug Analysis: Plecanatide (Year of Launch to 2022 (US$ Mn))
FIG. 13 U.S. IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 14 U.S. Prescribed IBS-C Drugs Market, by Prescription Type, 2017 - 2025 (USD Mn)
FIG. 15 Canada IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 16 U.K. IBS-C Drugs Market, 2017 - 2025 (%)
FIG. 17 Germany IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 18 Rest of Europe IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 19 Asia Pacific OIC Drugs Market, by Country, 2017 - 2025 (USD Mn)
FIG. 20 China IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 21 Japan IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 22 APAC IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 23 RoW IBS-C Drugs Market, by Region, 2017 - 2025 (USD Mn)
FIG. 24 Middle East and Africa OIC Drugs Market, 2017 - 2025 (USD Mn)
FIG. 25 Latin America IBS-C Drugs Market, 2017 - 2025 (USD Mn)
FIG. 26 Rest of RoW IBS-C Drugs Market, 2017 - 2025 (USD Mn)"

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +